Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Shree Renuka Sugars Ltd

RENUKA
Sugar

Shree Renuka Sugars Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.

Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work.

The price is in a downtrend (91 weeks in) while the P/E sits at the 73rd percentile of its own 1-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.

Price
₹21.9
−26.9% 1Y
P/E
0.8×
73rd pctile
of its own 1-year range
Revenue (Mar 26)
₹2,548 Cr
−5.3% YoY
Profit (Mar 26)
₹−121 Cr
−230.1% YoY
Operating margin
1.5%
−9.5 pp YoY
ROCE
−3%
FY26
ROIC
−7.0%
vs WACC 12.0% → −19.0 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Shree Renuka Sugars Ltd trades at ₹21.9, in a downtrend and 91 weeks into that stage. That is −15.0% against its own 200-day average. It sits at 0% of a 52-week range of ₹22 to ₹32. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (15 weeks and counting).

Today the stock is in a downtrend — week 91 of stage 4, confirmed. At ₹21.9 it trades −15.0% versus its 200-day average and sits at 0% of its 52-week range (₹22–₹32).

Jul 26: ₹21.9 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−15.0% versus the 200-day line, week 91 of stage 4
Price50-day avg200-day avg
S2S4S2S4₹57.9₹48.2₹38.5₹28.9₹19.2₹22₹26Jul 23May 24Feb 25Nov 25Jul 26
S2S4S2S4₹57.9₹48.2₹38.5₹28.9₹19.2₹22₹26Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (548 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +63% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (15 weeks and counting; last ahead the week of 2026-05-22) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Shree Renuka Sugars Ltd trades at 0.8× P/E, at the pricey end of its own range (73rd percentile). Its long-run median P/E is 0.8×, measured across 1.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 0.8× is at the pricey end of its own range (73rd percentile), against a long-run median of 0.8× measured over 1.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 0.8× vs a 0.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 1.0-year window. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (73rd percentile)
P/EMedianEPS (TTM) (quarterly)
1.3×₹13.21.1×₹9.90.8×₹6.60.6×₹3.30.4×₹0.0×0.80×₹12Nov 19Feb 20May 20Aug 20Nov 20
1.3×₹13.21.1×₹9.90.8×₹6.60.6×₹3.30.4×₹0.0×0.80×₹12Nov 19May 20Nov 20
PEG 0.29 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 12 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
1.1×0.9×0.6×0.4×0.2××0.29×Q2 FY22Q4 FY22Q4 FY23Q2 FY25Q4 FY26
1.1×0.9×0.6×0.4×0.2××0.29×Q2 FY22Q4 FY23Q4 FY26
P/E
0.8×
73rd percentile of 1y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Shree Renuka Sugars Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue −15.9% in FY26 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
47%−104.8%22%−105.1%−3.5%−105.5%−29%−105.8%−54%−106.1%%%−15.9%−106%FY16FY21FY26
47%−104.8%22%−105.1%−3.5%−105.5%−29%−105.8%−54%−106.1%%%−15.9%−106%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over
RevenueProfit
33%−225%19%−245%4.7%−265%−9.2%−285%−23%−306%%%−15.2%−230.1%Jun 23Sep 24Mar 26
33%−225%19%−245%4.7%−265%−9.2%−285%−23%−306%%%−15.2%−230.1%Jun 23Sep 24Mar 26
Revenue growth
Flat
latest −15.2% · span −19.3% to +28.7%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−15.9%+0.6%+10.2%−0.7%
Share price−26.9%−21.8%−8.6%+1.8%
Revenue YoY (Mar 26)
−5.3%
latest quarter vs a year ago
Profit YoY (Mar 26)
−230.1%
latest quarter vs a year ago
Revenue 10y
−0.7%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

17.1/100 — rank 19 of 20 in Sugar · 76% evidence confidence

Shree Renuka Sugars Ltd scores 17.1 out of 100 against the 20 companies it is compared with in Sugar, ranking 19. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 2.4 + 0.6 + 10 + 4.1 = 17.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Shree Renuka Sugars Ltd reported ₹2,548 Cr of revenue in the Mar 26 quarter, −5.3% year on year. Over 10 years it has compounded at −0.7% a year. The last full year, FY26, came in at ₹9,169 Cr. The last four reported quarters add to ₹9,254 Cr.

FY26 revenue came in at ₹9,169 Cr (−15.9% on the year), capping 10 years at −0.7% compound. The latest quarter (Mar 26) printed ₹2,548 Cr, −5.3% year on year.

FY26 revenue ₹9,169 Cr (−15.9% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
−0.7% a year over 10 years
RevenueYoY growth
12.8k47%9.6k22%6.4k−3.5%3.2k−29%0−54%₹ Cr%₹9,169−15.9%FY16FY21FY26
12.8k47%9.6k22%6.4k−3.5%3.2k−29%0−54%₹ Cr%₹9,169−15.9%FY16FY21FY26
Mar 26: ₹2,548 Cr (−5.3% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
3.6k51%2.7k28%1.8k5.4%912−18%0−41%₹ Cr%₹2,548−5.3%Jun 23Sep 24Mar 26
3.6k51%2.7k28%1.8k5.4%912−18%0−41%₹ Cr%₹2,548−5.3%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged −14.4% growth against the decade's −0.7% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −15.2% over the last 4 quarters against −9.4%/yr over the last 8 — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Shree Renuka Sugars Ltd's operating margin is 1.5% in the Mar 26 quarter, −9.5 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −42.0% to 10.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 1.5%, −9.5 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −42.0%–10.0%.

🚨 Why the margin moved: operating margin went −9.3 pp year on year while gross margin went −1.1 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 0.2% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −42.0–10.0% band over 13 years
operating marginYoY change (pp)
14%38%−0.9%16%−16%−6.5%−31%−29%−46%−51%%%0.2%−5.8%FY14FY20FY26
14%38%−0.9%16%−16%−6.5%−31%−29%−46%−51%%%0.2%−5.8%FY14FY20FY26
Mar 26: 1.5% operating margin (−9.5 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
13%13%7.0%5.2%1.5%−3.0%−4.0%−11%−9.5%−19%%%1.5%−9.5%Jun 23Sep 24Mar 26
13%13%7.0%5.2%1.5%−3.0%−4.0%−11%−9.5%−19%%%1.5%−9.5%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Shree Renuka Sugars Ltd posted a net loss of ₹121 Cr in the Mar 26 quarter. The full FY26 year was a loss of ₹792 Cr. That loss is 4.7% of the quarter's revenue. The same quarter a year earlier earned ₹93.0 Cr. 11 of the last 12 reported quarters were loss-making.

Mar 26 profit was ₹−121 Cr, −230.1% year on year. On the full year, FY26 printed ₹−792 Cr (null).

FY26 profit ₹−792 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
2.3k−104.8%1.1k−105.4%−127−106.0%−1.3k−106.6%−2.5k−107.2%₹ Cr%₹−792−106%FY16FY21FY26
2.3k−104.8%1.1k−105.4%−127−106.0%−1.3k−106.6%−2.5k−107.2%₹ Cr%₹−792−106%FY16FY21FY26
Mar 26: ₹−121 Cr (−230.1% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
130−142%0−461%−138−779%−272−1,098%−406−1,416%₹ Cr%₹−121−230.1%Jun 23Sep 24Mar 26
130−142%0−461%−138−779%−272−1,098%−406−1,416%₹ Cr%₹−121−230.1%Jun 23Sep 24Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Shree Renuka Sugars Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was ₹−122 Cr of operating cash against ₹−792 Cr of profit. After ₹−136 Cr of capital spending, ₹14.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY26: operating cash of ₹−122 Cr against reported profit of ₹−792 Cr, leaving free cash of ₹14.0 Cr after ₹−136 Cr of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹−122 Cr vs profit ₹−792 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY22 reflects an acquisition year — point shown clipped.
Operating cashNet profitFree cash
2.5k1.2k0−1.3k−2.6k₹ Cr₹−122₹−792₹14FY16FY21FY26
2.5k1.2k0−1.3k−2.6k₹ Cr₹−122₹−792₹14FY16FY21FY26
FY26: CFO = 29% of profit Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
106%85%65%44%23%%29%FY16FY21FY26
106%85%65%44%23%%29%FY16FY21FY26

Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Shree Renuka Sugars Ltd's cash conversion cycle runs 17 days in FY26, up from −12 days in FY21. Capital spending ran ₹514 Cr over the last 3 years. At FY26 sales of ₹9,169 Cr each day of that cycle holds about ₹25.1 Cr, so roughly ₹427 Cr sits inside the business at any moment.

FY26: debtors at 11 days, inventory at 127 days — roughly 4.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 17 days, looser than FY21's −12.

The full loop: cash goes out to suppliers and production on day 0; stock waits 127 days to sell; customers pay about 11 days after that; and suppliers themselves are paid at 121 days — netting out to the 17-day cycle.

In money terms: at FY26 sales of ₹9,169 Cr, each day of the cycle holds about ₹25.1 Cr — so the 17-day loop keeps roughly ₹427 Cr sitting inside the business at any moment.

FY26: a 17-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+29 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
31219783−31−146days17d127d11d121dFY14FY17FY20FY23FY26
31219783−31−146days17d127d11d121dFY14FY20FY26

On the investment side: capital spending of ₹514 Cr over the last 3 fiscal years against ₹838 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹24.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹−136 Cr, work-in-progress ₹24.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
steady investment
CapexWork-in-progress
2.8k1.6k299−963−2.2k₹ Cr₹−136₹24FY16FY18FY21FY23FY26
2.8k1.6k299−963−2.2k₹ Cr₹−136₹24FY16FY21FY26

The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Shree Renuka Sugars Ltd earns a ROCE of −3% in FY26. That is up from a trough of −182% in FY19. Return on invested capital clears the cost of that capital by −19.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −8.6% net margin on 1.24× asset turns.

FY26 ROCE is −3%, recovered from a FY19 trough of −182% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): −8.6% net margin × 1.24× asset turns × −2.77× balance-sheet leverage ≈ 29.5% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: −7.0% − 12.0% = a −19.0 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE −3% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 12-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY19's −182%
ROCEROIC (annual)WACC
36%−23%−81%−140%−198%%−3%−4.4%FY14FY19FY26
36%−23%−81%−140%−198%%−3%−4.4%FY14FY19FY26
Q4 FY26: ROCE 3.6% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
34%21%8.9%−3.7%−16%%3.6%0.5%Q2 FY22Q4 FY23Q4 FY26
34%21%8.9%−3.7%−16%%3.6%0.5%Q2 FY22Q4 FY23Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Shree Renuka Sugars Ltd's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from −8.62 in FY22 to −2.68 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹7,174 Cr against shareholder equity of ₹−2,677 Cr — a debt-to-equity of −2.68. On the annual view, debt-to-equity went from −8.62 (FY22) to −2.68 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹7,174 Cr at −2.68× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
7.7k−2.2×5.8k−3.9×3.9k−5.6×1.9k−7.4×0−9.1×₹ Cr×₹7,174−2.68×FY22FY24FY26
7.7k−2.2×5.8k−3.9×3.9k−5.6×1.9k−7.4×0−9.1×₹ Cr×₹7,174−2.68×FY22FY24FY26
Mar 26: debt ₹7,174 Cr, debt-to-equity −2.68 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
7.7k−2.4×5.8k−3.4×3.9k−4.5×1.9k−5.6×0−6.6×₹ Cr×₹7,174−2.68×Jun 23Sep 24Mar 26
7.7k−2.4×5.8k−3.4×3.9k−4.5×1.9k−5.6×0−6.6×₹ Cr×₹7,174−2.68×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 1.3 points of Shree Renuka Sugars Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 2.2% of the company. Domestic institutions moved −0.9 points over the same window, to 9.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −1.3 points over 8 quarters to 2.2%; Domestic institutions: −0.9 points over 8 quarters to 9.1%; Promoters: +0.0 points over 8 quarters to 62.5%.

🚨 Why the register moved: foreign institutions drove it (−1.3 points), alongside domestic institutions (−0.9 points) — distribution into the market’s bid.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
67%50%33%16%−1.4%%62.5%3.5%10.1%23.9%Mar 24Mar 25Mar 26
67%50%33%16%−1.4%%62.5%3.5%10.1%23.9%Mar 24Mar 25Mar 26
Foreign institutions cut 1.3 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
67%50%32%15%−2.7%%62.5%2.2%9.1%26.2%Jun 23Dec 24Jun 26
67%50%32%15%−2.7%%62.5%2.2%9.1%26.2%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Shree Renuka Sugars Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Sugar
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Andhra Sugars LtdANDHRSUGAR 65.7/100Favorable setup83% evidence FADING 26.7/35 Revenue 22.1% · PAT 100% · OPM change -1.8 pp 83% evidence 12.9/25 ROCE 8.5% · OPM 7.5% 95% evidence 13.0/20 P/E 11.2× · PEG — 50% evidence 13.1/20 RS sector 8.6% · RS bench 1.9% · 1Y 2.2%6 of 12 weeks ahead 100% evidence
Exact sum: 26.7 + 12.9 + 13 + 13.1 = 65.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2DCM Shriram LtdDCMSHRIRAM 60.5/100Mixed-positive evidence100% evidence ASLEEP 23.8/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence 13.0/25 ROCE 11.5% · OPM 9% 100% evidence 16.8/20 P/E 11.8× · PEG 0.44 100% evidence 6.9/20 RS sector -6.5% · RS bench -12% · 1Y -26%0 of 12 weeks ahead 100% evidence
Exact sum: 23.8 + 13 + 16.8 + 6.9 = 60.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.5% and the one-year return is -26%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
3Uttam Sugar Mills LtdUTTAMSUGAR 58.4/100Mixed-positive evidence70% evidence ASLEEP 23.1/35 Revenue 19.2% · PAT 17.4% · OPM change 1 pp 83% evidence 17.1/25 ROCE 11.5% · OPM 21% 95% evidence 11.2/20 P/E 8.4× · PEG — 15% evidence 7.0/20 RS sector -9.1% · RS bench -8.2% · 1Y -17.3%5 of 10 weeks ahead 70% evidence
Exact sum: 23.1 + 17.1 + 11.2 + 7 = 58.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4M.V.K. Agro Food Product LtdMVKAGRO 56.6/100Thin evidence · provisional52% evidence ASLEEP 18.2/35 Revenue — · PAT — · OPM change 17 pp 32% evidence 17.6/25 ROCE 14.4% · OPM 22% 95% evidence 8.8/20 P/E 35.8× · PEG — 15% evidence 12.0/20 RS sector 33.8% · RS bench -37.8% · 1Y 47.2%0 of 10 weeks ahead 70% evidence
Exact sum: 18.2 + 17.6 + 8.8 + 12 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Bannari Amman Sugars LtdBANARISUG 55.0/100Mixed-positive evidence96% evidence BASING 17.9/35 Revenue 6.9% · PAT 42.3% · OPM change -9.7 pp 88% evidence 14.9/25 ROCE 9.3% · OPM 1.3% 100% evidence 9.6/20 P/E 29.5× · PEG 1.75 100% evidence 12.6/20 RS sector 0.9% · RS bench -5% · 1Y -7.8%0 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 14.9 + 9.6 + 12.6 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Dalmia Bharat Sugar & Industries LtdDALMIASUG 54.2/100Mixed-positive evidence96% evidence ASLEEP 9.6/35 Revenue -3.2% · PAT -37.7% · OPM change -2 pp 88% evidence 13.1/25 ROCE 8.2% · OPM 17% 100% evidence 14.3/20 P/E 12.3× · PEG 0.48 100% evidence 17.2/20 RS sector 9.6% · RS bench 2.8% · 1Y -7.3%4 of 12 weeks ahead 100% evidence
Exact sum: 9.6 + 13.1 + 14.3 + 17.2 = 54.2 · Decision use: Price leads the evidence: RS versus the benchmark is 2.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7Dhampur Sugar Mills LtdDHAMPURSUG 52.4/100Mixed-positive evidence87% evidence ASLEEP 20.5/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence 8.5/25 ROCE 6.4% · OPM 5.7% 95% evidence 9.0/20 P/E 12.4× · PEG — 50% evidence 14.4/20 RS sector 7% · RS bench 0.4% · 1Y -6.8%5 of 12 weeks ahead 100% evidence
Exact sum: 20.5 + 8.5 + 9 + 14.4 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8EID Parry (India) LtdEIDPARRY 50.9/100Mixed-positive evidence72% evidence ASLEEP 19.9/35 Revenue 21.9% · PAT -22.2% · OPM change 0 pp 83% evidence 16.9/25 ROCE 17% · OPM 8% 76% evidence 9.6/20 P/E 20.6× · PEG — 50% evidence 4.5/20 RS sector -20.5% · RS bench -18.4% · 1Y -35.3%0 of 10 weeks ahead 70% evidence
Exact sum: 19.9 + 16.9 + 9.6 + 4.5 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Balrampur Chini Mills LtdBALRAMCHIN 50.3/100Mixed-positive evidence96% evidence BREAKING OUT 15.3/35 Revenue 15.8% · PAT -13.1% · OPM change -6 pp 88% evidence 13.2/25 ROCE 9.3% · OPM 18% 100% evidence 2.4/20 P/E 32.7× · PEG 2.21 100% evidence 19.4/20 RS sector 24% · RS bench 16.5% · 1Y -0.5%8 of 12 weeks ahead 100% evidence
Exact sum: 15.3 + 13.2 + 2.4 + 19.4 = 50.3 · Decision use: Price leads the evidence: RS versus the benchmark is 16.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
10Dhampur Bio Organics LtdDBOL 48.1/100Mixed-negative evidence72% evidence ASLEEP 21.0/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence 6.1/25 ROCE 5% · OPM 1.7% 95% evidence 9.7/20 P/E 25.4× · PEG — 15% evidence 11.3/20 RS sector 7.7% · RS bench 1% · 1Y 10.7%5 of 12 weeks ahead 100% evidence
Exact sum: 21 + 6.1 + 9.7 + 11.3 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Avadh Sugar & Energy LtdAVADHSUGAR 47.7/100Mixed-negative evidence83% evidence BREAKING OUT 8.9/35 Revenue 2.2% · PAT -34.8% · OPM change -4 pp 83% evidence 11.6/25 ROCE 6.8% · OPM 18% 95% evidence 8.1/20 P/E 16.1× · PEG — 50% evidence 19.1/20 RS sector 24.1% · RS bench 16.2% · 1Y 8.5%7 of 12 weeks ahead 100% evidence
Exact sum: 8.9 + 11.6 + 8.1 + 19.1 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 16.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
12Bajaj Hindusthan Sugar LtdBAJAJHIND 47.6/100Mixed-negative evidence90% evidence ASLEEP 22.4/35 Revenue -2.2% · PAT 100% · OPM change 4 pp 88% evidence 9.4/25 ROCE 2.3% · OPM 22% 100% evidence 11.1/20 P/E 28.5× · PEG 1.32 100% evidence 4.7/20 RS sector -21% · RS bench -12.7% · 1Y -33.2%6 of 11 weeks ahead 70% evidence
Exact sum: 22.4 + 9.4 + 11.1 + 4.7 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Godavari Biorefineries LtdGODAVARIB 44.3/100Mixed-negative evidence76% evidence ASLEEP 20.1/35 Revenue 6.3% · PAT 100% · OPM change -4 pp 83% evidence 9.2/25 ROCE 6.5% · OPM 15% 95% evidence 8.7/20 P/E 39.7× · PEG — 15% evidence 6.3/20 RS sector -2.3% · RS bench -8.3% · 1Y -17.1%2 of 12 weeks ahead 100% evidence
Exact sum: 20.1 + 9.2 + 8.7 + 6.3 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Zuari Industries LtdZUARIIND 43.1/100Mixed-negative evidence62% evidence ASLEEP 18.8/35 Revenue 7.7% · PAT 100% · OPM change 1 pp 62% evidence 8.1/25 ROCE 5.5% · OPM 11% 95% evidence 11.5/20 P/E 6.6× · PEG — 15% evidence 4.7/20 RS sector -26.8% · RS bench -10.8% · 1Y -2.4%2 of 10 weeks ahead 70% evidence
Exact sum: 18.8 + 8.1 + 11.5 + 4.7 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Triveni Engineering and Industries LtdTRIVENI 36.7/100Mixed-negative evidence82% evidence ASLEEP 18.0/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence 9.6/25 ROCE 6.8% · OPM 3.4% 76% evidence 6.8/20 P/E 18.6× · PEG — 50% evidence 2.3/20 RS sector -33.2% · RS bench -3.8% · 1Y -39.6%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 9.6 + 6.8 + 2.3 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Davangere Sugar Company LtdDAVANGERE 36.3/100Mixed-negative evidence70% evidence 14.4/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence 8.9/25 ROCE 5.6% · OPM 10.1% 95% evidence 8.5/20 P/E 58.6× · PEG — 15% evidence 4.5/20 RS sector -25% · RS bench -12.6% · 1Y -47%1 of 8 weeks ahead 70% evidence
Exact sum: 14.4 + 8.9 + 8.5 + 4.5 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Magadh Sugar & Energy LtdMAGADSUGAR 36.0/100Mixed-negative evidence77% evidence ASLEEP 6.4/35 Revenue -5.9% · PAT -41.3% · OPM change -5 pp 83% evidence 11.9/25 ROCE 7.8% · OPM 27% 95% evidence 10.1/20 P/E 11.1× · PEG — 50% evidence 7.6/20 RS sector -19.1% · RS bench -0.8% · 1Y -11.1%2 of 10 weeks ahead 70% evidence
Exact sum: 6.4 + 11.9 + 10.1 + 7.6 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Dwarikesh Sugar Industries LtdDWARKESH 35.1/100Thin evidence · provisional54% evidence ASLEEP 16.7/35 Revenue 20.1% · PAT -80% · OPM change -8.2 pp 31% evidence 3.7/25 ROCE 5% · OPM -7.2% 80% evidence 9.5/20 P/E 25.6× · PEG — 15% evidence 5.2/20 RS sector -5.6% · RS bench -11.4% · 1Y -17.8%5 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 3.7 + 9.5 + 5.2 = 35.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19Shree Renuka Sugars Ltdthis pageRENUKA 17.1/100Adverse evidence76% evidence ASLEEP 2.4/35 Revenue -15.2% · PAT -80% · OPM change -9.5 pp 88% evidence 0.6/25 ROCE -3.1% · OPM 1.5% 100% evidence 10.0/20 P/E — · PEG — 0% evidence 4.1/20 RS sector -12.9% · RS bench -18.2% · 1Y -29.2%0 of 12 weeks ahead 100% evidence
Exact sum: 2.4 + 0.6 + 10 + 4.1 = 17.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20DCM Shriram Industries LtdDCMSRIND 43.1/100Thin evidence · provisional48% evidence 12.3/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence 14.0/25 ROCE 13.7% · OPM 1.8% 71% evidence 8.8/20 P/E 8.2× · PEG — 50% evidence 8.0/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence
Exact sum: 12.3 + 14 + 8.8 + 8 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Shree Renuka Sugars Ltd's share price today?

Shree Renuka Sugars Ltd trades at ₹21.9, −26.9% over the past year. The company is valued at ₹4,655 Cr. The stock sits at 0% of its 52-week range of ₹22–₹32, −15.0% versus its 200-day average. On the tape, the price is in a downtrend, 91 weeks in. — as of 31 July 2026.

What were Shree Renuka Sugars Ltd's latest quarterly results?

Shree Renuka Sugars Ltd reported revenue of ₹2,548 Cr and a net loss of ₹121 Cr for the Mar 26 quarter. Revenue fell 5.3% and profit fell 230.1% year on year. Earnings per share were ₹−0.57. The operating margin was 1.5%, 9.5 pp lower than a year earlier. — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's revenue?

Shree Renuka Sugars Ltd reported revenue of ₹2,548 Cr in the Mar 26 quarter, −5.3% year on year. For the full FY26 fiscal year, revenue was ₹9,169 Cr (−15.9%). Over the last 10 years revenue compounded at −0.7% a year. — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's profit?

Shree Renuka Sugars Ltd earned ₹−121 Cr of net profit in the Mar 26 quarter, −230.1% year on year. Full-year FY26 profit was ₹−792 Cr. The operating margin ran 1.5% in the latest quarter. — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's market cap?

Shree Renuka Sugars Ltd's market capitalisation is ₹4,655 Cr at a share price of ₹21.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's P/E ratio?

Shree Renuka Sugars Ltd trades at a P/E of 0.8×, at the 73rd percentile of its own 1-year range, against a long-run median of 0.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Shree Renuka Sugars Ltd pay a dividend?

No — Shree Renuka Sugars Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.

Is Shree Renuka Sugars Ltd overvalued?

On its own history, Shree Renuka Sugars Ltd looks expensive against its own history: its P/E of 0.8× sits at the 73rd percentile of its 1-year range (long-run median 0.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Shree Renuka Sugars Ltd growing?

Not right now — Shree Renuka Sugars Ltd's latest numbers are shrinking: latest-quarter revenue −5.3% year on year, profit −230.1%, and the margin −9.5 pp at 1.5%. The earnings engine currently reads: deteriorating — as of 31 July 2026.

How is Shree Renuka Sugars Ltd performing?

Shree Renuka Sugars Ltd is in a downtrend, 91 weeks in. Its latest quarter's revenue fell 5.3% and profit fell 230.1% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 15 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

Is Shree Renuka Sugars Ltd in an uptrend?

No — the price is in a downtrend (week 91 of stage 4), trading −15.0% versus its 200-day average and at 0% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Shree Renuka Sugars Ltd beating the market?

Not lately — on a trailing-13-week view Shree Renuka Sugars Ltd is currently behind the NIFTY 500 (15 weeks and counting; last ahead the week of 2026-05-22), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +63% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.

Will Shree Renuka Sugars Ltd's share price go up?

This page publishes no price forecast for Shree Renuka Sugars Ltd. What it measures instead: the share price is ₹21.9, the price is in a downtrend 91 weeks in. Its P/E of 0.8× sits at the 73rd percentile of its own 1-year range. — as of 31 July 2026.

Who owns Shree Renuka Sugars Ltd?

Promoters hold 62.5% of Shree Renuka Sugars Ltd, foreign institutions 2.2%, domestic institutions 9.1% and the public 26.2% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 1.3 points over 8 quarters. — as of 31 July 2026.

Does Shree Renuka Sugars Ltd have too much debt?

No — Shree Renuka Sugars Ltd's debt-to-equity is −2.68, and operating profit covers the interest bill 0×. FY26 borrowings were ₹7,174 Cr against equity of ₹−2,677 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's capex?

Shree Renuka Sugars Ltd spent ₹514 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹−136 Cr, with ₹24.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Shree Renuka Sugars Ltd's cash flow?

Shree Renuka Sugars Ltd generated ₹−122 Cr of operating cash flow in FY26 and ₹14.0 Cr of free cash flow after ₹−136 Cr of capital spending. Reported profit that year was ₹−792 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Where is Shree Renuka Sugars Ltd in its business cycle?

Shree Renuka Sugars Ltd's FY26 operating margin was 0.2%, against a 13-year band of −42.0%–10.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 1.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Shree Renuka Sugars Ltd story?

Biggest watch item: the P/E sits at the 73rd percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Shree Renuka Sugars Ltd a stock worth studying right now?

This is not investment advice. The machine read: Shree Renuka Sugars Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI